The North America Hydrogel-based Drug Delivery System Market would witness market growth of 7.4% CAGR during the forecast period (2021-2027).
The growth of the hydrogel-based drug delivery system market would witness a surge due to the factors like rising number of studies to improve hydrogel-based protein delivery, the growing prevalence of CNS disorders, and increasing investment in hydrogel-based drug delivery systems. European Union in 2021 announced the investment for 13 projects that include the making of a hyaluronan-based hydrogel system in mucosal drug delivery. The project is estimated to come to the market in Oct 2021 and would continue in the next three years. These kinds of initiatives are projected to develop the latest hydrogel-based drug delivery systems, thus bolstering the market growth.
The presence of key market players in this region is pushing the regional hydrogel-based drug delivery system market forward. In addition, the prevalence of efficient reimbursement policies, which cover the cost of modern therapies, is contributing to propelling demand for hydrogel-based drug delivery systems across the region. The increasing number of clinical trials in this region is opening new growth prospects for the regional market growth.
Moreover, the increasing cases of various diseases like bacterial vaginosis, especially in the US are estimated to bolster the growth of the market during the forecast period. All these factors are motivating the companies to expand their regional market share and thus, fuel the growth of the hydrogel-based drug delivery system market in this region.
The US market dominated the North America Hybrid Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $361.3 Million by 2027. The Canada market is experiencing a CAGR of 10.8% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 10% during (2021 - 2027).
Based on Polymer Origin, the market is segmented into Synthetic, Natural and Hybrid. Based on Delivery Route, the market is segmented into Ocular, Subcutaneous, Oral Cavity, Topical and Other Delivery Routes. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Hydrogel-based Drug System Market is Estimated to Reach USD 9.3 Billion by 2027 at a CAGR of 8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Bausch Health Companies, Inc., Medtronic PLC, Galderma S.A., Endo International PLC, Ferring Holdings SA, Akorn Operating Company LLC, Tolmar Pharmaceuticals, Inc., Blairex Laboratories, Inc., and Ocular Therapeutix, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Polymer Origin
By Delivery Route
- Ocular
- Subcutaneous
- Oral Cavity
- Topical
- Other Delivery Routes
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- Bausch Health Companies, Inc.
- Medtronic PLC
- Galderma S.A.
- Endo International PLC
- Ferring Holdings SA
- Akorn Operating Company LLC
- Tolmar Pharmaceuticals, Inc.
- Blairex Laboratories, Inc.
- Ocular Therapeutix, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hydrogel-based Drug System Market, by Polymer Origin
1.4.2 North America Hydrogel-based Drug System Market, by Delivery Route
1.4.3 North America Hydrogel-based Drug System Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Hydrogel-based Drug Delivery System Market by Polymer Origin
3.1 North America Synthetic Market by Country
3.2 North America Natural Market by Country
3.3 North America Hybrid Market by Country
Chapter 4. North America Hydrogel-based Drug Delivery System Market by Delivery Route
4.1 North America Ocular Market by Country
4.2 North America Subcutaneous Market by Country
4.3 North America Oral Cavity Market by Country
4.4 North America Topical Market by Country
4.5 North America Other Delivery Routes Market by Country
Chapter 5. North America Hydrogel-based Drug Delivery System Market by Country
5.1 US Hydrogel-based Drug Delivery System Market
5.1.1 US Hydrogel-based Drug Delivery System Market by Polymer Origin
5.1.2 US Hydrogel-based Drug Delivery System Market by Delivery Route
5.2 Canada Hydrogel-based Drug Delivery System Market
5.2.1 Canada Hydrogel-based Drug Delivery System Market by Polymer Origin
5.2.2 Canada Hydrogel-based Drug Delivery System Market by Delivery Route
5.3 Mexico Hydrogel-based Drug Delivery System Market
5.3.1 Mexico Hydrogel-based Drug Delivery System Market by Polymer Origin
5.3.2 Mexico Hydrogel-based Drug Delivery System Market by Delivery Route
5.4 Rest of North America Hydrogel-based Drug Delivery System Market
5.4.1 Rest of North America Hydrogel-based Drug Delivery System Market by Polymer Origin
5.4.2 Rest of North America Hydrogel-based Drug Delivery System Market by Delivery Route
Chapter 6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 Bausch Health Companies, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Product Launches and Product Expansions:
6.3 Medtronic PLC
6.3.1 Company overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 Galderma S.A.
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Partnerships, Collaborations, and Agreements:
6.4.2.2 Approvals & Trials:
6.5 Endo International PLC
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.5.4 Research & Development Expenses
6.6 Ferring Holdings SA
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research and Development Expense
6.7 Akorn Operating Company LLC
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Approvals & Trials:
6.8 Tolmar Pharmaceuticals, Inc.
6.8.1 Company Overview
6.9 Blairex Laboratories, Inc.
6.9.1 Company Overview
6.10. Ocular Therapeutix, Inc.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Research & Development Expenses
6.10.4 Recent strategies and developments:
6.10.4.1 Partnerships, Collaborations, and Agreements:
6.10.4.2 Approvals & Trials:
TABLE 1 North America Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 2 North America Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 3 North America Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 4 North America Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 5 North America Synthetic Market by Country, 2017 - 2020, USD Million
TABLE 6 North America Synthetic Market by Country, 2021 - 2027, USD Million
TABLE 7 North America Natural Market by Country, 2017 - 2020, USD Million
TABLE 8 North America Natural Market by Country, 2021 - 2027, USD Million
TABLE 9 North America Hybrid Market by Country, 2017 - 2020, USD Million
TABLE 10 North America Hybrid Market by Country, 2021 - 2027, USD Million
TABLE 11 North America Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 12 North America Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 13 North America Ocular Market by Country, 2017 - 2020, USD Million
TABLE 14 North America Ocular Market by Country, 2021 - 2027, USD Million
TABLE 15 North America Subcutaneous Market by Country, 2017 - 2020, USD Million
TABLE 16 North America Subcutaneous Market by Country, 2021 - 2027, USD Million
TABLE 17 North America Oral Cavity Market by Country, 2017 - 2020, USD Million
TABLE 18 North America Oral Cavity Market by Country, 2021 - 2027, USD Million
TABLE 19 North America Topical Market by Country, 2017 - 2020, USD Million
TABLE 20 North America Topical Market by Country, 2021 - 2027, USD Million
TABLE 21 North America Other Delivery Routes Market by Country, 2017 - 2020, USD Million
TABLE 22 North America Other Delivery Routes Market by Country, 2021 - 2027, USD Million
TABLE 23 North America Hydrogel-based Drug Delivery System Market by Country, 2017 - 2020, USD Million
TABLE 24 North America Hydrogel-based Drug Delivery System Market by Country, 2021 - 2027, USD Million
TABLE 25 US Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 26 US Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 27 US Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 28 US Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 29 US Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 30 US Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 31 Canada Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 32 Canada Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 33 Canada Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 34 Canada Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 35 Canada Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 36 Canada Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 37 Mexico Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 38 Mexico Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 39 Mexico Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 40 Mexico Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 41 Mexico Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 42 Mexico Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 43 Rest of North America Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 44 Rest of North America Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 45 Rest of North America Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 46 Rest of North America Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 47 Rest of North America Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 48 Rest of North America Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 49 Key information –Johnson & Johnson
TABLE 50 key information – Bausch Health Companies, Inc.
TABLE 51 Key Information – Medtronic PLC
TABLE 52 Key Information – Galderma S.A.
TABLE 53 key Information – Endo International PLC
TABLE 54 key information – Ferring Holdings SA
TABLE 55 Key information - Akorn Operating Company LLC
TABLE 56 Key Information – Tolmar Pharmaceuticals, Inc.
TABLE 57 Key Information – Blairex Laboratories, Inc.
TABLE 58 Key information - Ocular Therapeutix, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Bausch Health Companies, Inc.